Bill & Melinda Gates Foundation — Full Portfolio

CDD provides software for collaborative research and discovery in biological and chemical sciences, serving scientists and organizations globally.

AI & Machine LearningBiotechData & InfrastructureEnterprise SoftwareSaaS

Barry Bunin(Founder & CEO)

A searchable database of peer-reviewed evidence on the benefits of immunization, designed for child health advocates, researchers, and policymakers.

Digital HealthHealthtechImpact & Social GoodBaltimore, US

Co-investorsICONIQ

Neurosynaptic Communications provides customized healthcare delivery solutions and telemedicine services designed for primary healthcare centers and underserved regions.

AI & Machine LearningDigital HealthHealthtechImpact & Social GoodSaaS

Sameer Sawarkar(Founder and CEO)Rajeev Kumar(Founder and COO)in

Co-investorsHealthQuadVenturEast

Pula is an investment and advisory firm that operates an accelerator program in partnership with Nigeria's Sovereign Investment Authority, supporting early-stage ventures in climate resilience, agricultural technology, insurance technology, and regulatory technology across African markets.

AgTechClimate TechInsurTechNairobi, ZA

Thomas Njeru(Co-Founder and CEO)inRose Goslinga(Co-Founder and President)in

Co-investorsAccionInternational Finance CorporationMulago FoundationTLcom CapitalIFC

Raydiant Oximetry is developing technology to reduce complications and emergency interventions during childbirth.

Digital HealthFemTechHealthtechMedical DevicesSan Ramon, US

Neil P. Ray(Executive Officer, Director)inMichael Nagel(Chief Executive Officer)in

BoardCharles McDonald(Director)John Maroney(Director)

Co-investorsBand of AngelsFemHealth VenturesSteelSky VenturesTri-Valley VenturesAvestria VenturesRhia Ventures+3 more

Sanaria develops malaria vaccines designed to prevent infection in at-risk populations worldwide, including pregnant women and children, with long-term goals of mass immunization campaigns and disease elimination.

BiotechHealthtechImpact & Social GoodMedical Devices

Stephen L. Hoffman(CEO)

Stellapps builds the SmartMoo™ full-stack IoT platform that digitizes and optimizes milk production, procurement, and cold-chain management using sensors, big data, and machine learning.

AgTechFoodTechIoTSaaSBangalore, IN

Ranjith Mukundan(Founder)inRamakrishna Adukuri(Founder)inPraveen NaleRavishankar ShiroorinVenkatesh SeshasayeeinYawar Usmaniin

Co-investors500 GlobalBlue Ashva CapitalQualcomm Ventures

Syntis Bio develops oral therapies that use the biology of the small intestine to treat conditions ranging from rare genetic disorders to common diseases.

BiotechDeep TechDigital HealthHealthtechBoston, US

Rahul Dhanda(Executive Officer, Director)inCarlo Giovanni Traverso(Director)Robert Langer(Director)

BoardTeymour Boutros-Ghali(Director)inTEYMOUR BOUTROS-GHALI(Director)inMartin Madaus(Director)

Co-investorsBold Capital PartnersCerity Partners VenturesPortal InnovationsSafar Partners

Pittsburgh, US

Allison Pendergast(Executive Officer)William L. Guttman(Executive Officer, Director)Dennis Farkos(Executive Officer)Lukman Ramsey(Executive Officer)Eric Frank(Executive Officer, Director)Jay Panzarella(Executive Officer)

Co-investorsDraper TriangleHearst Ventures

Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment.

BiotechHealthtechMedical DevicesBoston, US

Co-investors5AM VenturesAju IB Invesment CorporationCatalio Capital Management, LPDelos CapitalF-Prime CapitalSolasta Ventures+7 more

Uses a T-cell antigen discovery platform to develop vaccines for oncology and infectious disease.

BiotechCambridge, US

Narinder Singh(Executive Officer)Derek Meisner(Executive Officer)Michael Alfieri(Executive Officer)Jessica Flechtner(Executive Officer)Girish Aakalu(Executive Officer)Thomas Davis(Executive Officer)

Co-investorsCycad Group LLCLux CapitalMC Healthcare VenturesAdvent Life SciencesAlexandriaAuriga Partners+1 more

Infinant Health develops probiotic products based on B. infantis strains that work with breast milk to support the infant gut microbiome, including its INF108 drug strain aimed at preventing necrotizing enterocolitis (NEC) in premature infants.

BiotechDigital HealthFemTechHealthtechWellness & FitnessSacramento, US

J. Bruce German(Co-founder)David Mills(Co-founder)inCarlito Lebrilla(Co-founder)Daniela Barile(Co-founder)Samara Freeman(Co-founder & Director of Intellectual Property and Regulatory Affairs)inMichael Johnson(Executive Officer, Director)

Co-investorsAcre Venture PartnersBow CapitalHorizons VenturesiSelect FundLongitude CapitalSpruce Capital Partners

Loowatt develops a patented waterless, chemical-free flush toilet that seals waste in a lining and offers end-to-end sanitation-as-a-service, including servicing and processing of waste into biogas and fertiliser via anaerobic digestion.

Circular EconomyCleantechHardware

Virginia Gardiner(CEO + Founder)

Co-investorsAngel AcademeOxford Investment Opportunity Network (OION)

BiotechWatertown, US

Carlo Giovanni Traverso(Director)Amy W. Schulman(Executive Officer, Director)inRobert S. Langer(Director)

BoardZafi Avnur(Director)Edmund Harrigan(Director)Catherine Reynolds(Director)

Co-investorsKendall Capital PartnersPolaris Partners

Phase Genomics develops long-range genome sequencing technology based on proximity ligation, along with computational tools, for scientists studying cancer, inherited diseases, microbiomes, and biodiversity.

AI & Machine LearningBiotechHealthtechSeattle, US

Ivan Liachko(Executive Officer, Director, Promoter)inShawn Sullivan(Executive Officer, Promoter)in

Co-investorsCongruent VenturesHemi Ventures, LlcAlliance of Angels